Our history

Straumann – more than half a century of experience and research.

Prof Reinhard Straumann

Focus on implants

In 1954, Reinhard Straumann founded the Dr. Ing. R. Straumann Research Institute AG. Until 1970, the company specialized in materials testing and alloys for timing instruments. Four years later, Straumann presented its first dental implants, including the world’s first one-stage implant.

By 1990, Straumann was a leading manufacturer of osteosynthesis implants. A management buyout of the osteosynthesis division in 1990 – leading to the creation of a separate company now known as Synthes – marked the beginning of Straumann as it is known today.

Global Headquarters

Straumann today

In 1998, Straumann Holding AG became publicly traded on the Swiss Exchange. The year 2000 saw the opening of the production site in Villeret and the Technology Center in Waldenburg. In 2004 Straumann moved to its new global headquarters in Basel.

Since 2003, Straumann has expanded its portfolio to include products for oral tissue regeneration, CADCAM (computer-aided design and manufacturing), guided surgery and intra-oral scanning.


Driving the expansion in the value implant segment in Asia/Pacific

Straumann invests in MegaGen, South Korea's fast-growing dental implant company, to drive expansion in value implant segment in Asia/Pacific.

Straumann teams up with botiss

Straumann and botiss announced their collaboration to provide complete oral tissue regeneration solutions to dental professionals worldwide.


Straumann introduces new ceramic implant

Exceptional esthetic properties with a translucent ivory color like natural tooth roots: The Straumann PURE ceramic implant has a specially-developed ZLA® surface to enhance and shorten the healing process and to provide highly predictable osseointegration. Its manufacture involves several innovations including a test procedure to assure the stability of every implant.

Further steps to penetrate the value segment

After the Group’s first step outside the premium segment was taken in 2012 when it acquired 49% of Brazilian market leader Neodent, Straumann advanced its strategy to become a global leader also in the ‘value’ segment of the tooth-replacement market through investing in Medentika in Germany, a rapidly-expanding provider of cost-effective implants and prosthetics for multiple implant systems, and Createch Medical in Spain, a specialist in high-end CADCAM prosthetics for multiple implant systems. Also in 2013, Neodent products were introduced in Spain.


Straumann acquires 49% of Neodent, Brazil’s leading dental implant company

Large clinical study of Straumann SLA tissue-level dental implants at the Berne University in Switzerland yields impressive 10-year outcomes


Minority stake in Dental Wings and collaboration with 3M ESPE to integrate DWOS® (Dental Wings Open Software) platform


2010 Straumann® CARES® Digital Solutions platform connecting dental professionals across disciplines; exclusive distribution of CADENT iTero intra-oral scanning solution; Straumann® MembraGel liquid membrane


Roxolid® – the new high-strength material for dental implants which is stronger than titanium and shows excellent osseointegration; acquisition of the dental business of IVS Solutions AG; coDiagnostiX™ software for guided surgery


Acquisition of etkon, a leader in CADCAM-based tooth restorations (now Straumann CADCAM GmbH); Straumann® Bone Level implants designed for maximum flexibility and minimum complexity


SLActive® – the implant surface designed to offer shorter healing times, improved bone formation and therefore reduced risk of implant loss1; bone regeneration with Straumann® BoneCeramic


Acquisition of Swedish company Biora; oral tissue regeneration with Straumann® Emdogain


synOcta® - the system for a new level of flexibility in prosthetics


SLA® – the pioneering surface technology cuts healing time in half2

1 Straumann® SLActive Scientific Evidence, Fifth Edition, 2010.
2 Scacchi M. et al, The development of the ITI DENTAL IMPLANT SYSTEM. Part 2: 1998-2000: Steps into the next millennium. Clin Oral Implants Res 2000; 11:22-32

iTero™ is a trademark of Cadent Ltd., Israel.
DWOS® is a registered trademark of Dental Wings Inc., Canada.